OPZELURA crème 15 mg/g tb 100 g
7680694430012
CH-69443
D11AH09
10.99.0.
Reimbursement limitations:
OPZELURA.01
Vitiligo chez les adultes et les adolescents dès 12 ans
Le traitement exige une garantie …
1 / 3
google
Details
- Product number
- 6944301
- CPT
- -
- Packaging group
- 100
- Unit
- g
- Composition
- ruxolitinibum 15 mg ut ruxolitinibi phosphas, propylenglycolum 150 mg, E 218 1 mg, propylis parahydroxybenzoas 0.5 mg, xanthani gummi, paraffinum liquidum, glyceroli monopalmitostearas, polysorbatum 20, vaselinum album, E 321 1.4 µg, alcohol cetylicus 30 mg, alcohol stearylicus 17.5 mg, dimeticonum 350, triglycerida media, aqua purificata, dinatrii edetas, macrogolum 200, phenoxyethanolum, ad unguentum pro 1 g.
Articles (1)
Opzelura 15 mg/g, crème
Crème
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
150.0 MG | Substance | HBESI |
|
(N/A)
|
1.0 MG | Substance | HBESI |
|
(N/A)
|
0.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.4 UG | Substance | HBESI |
|
(N/A)
|
30.0 MG | Substance | HBESI |
|
(N/A)
|
17.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | Konservierungsstoff (Conservateur) |
Reimbursement information
Public price
CHF 785.20
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/06/2025
Authorization holder
Incyte Biosciences International
1110 Morges
Authorization information
- Swissmedic authorization number
- 69443
- Drug name
- Opzelura, crème
- Galenic form
- CREM
- ATC Code
- D11AH09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/01/2025
- Authorization expiration date
- 29/01/2030
- IT number
- 10.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OPZELURA crème 15 mg/g tb 100 g
- Description (DE)
- OPZELURA Creme 15 mg/g Tb 100 g
- Market launch
- 30/01/2025
- Narcotic (BTM)
- No